Authors
Loading...
Randomized trial demonstrates GO-Y078 triggers cell death in cervical cancer cells, indicating therapeutic potential.
Lee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: